OraSure receives FDA clearance for at-home STI urine collection kit
Go back to OraSure receives FDA clearance for at-home STI urine collection kit| OraSure Technologies, Inc. (NASDAQ: OSUR) | Delayed: 4.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.16 | 52 Week High | $9.05 | |||
| Open | $4.16 | 52 Week Low | $5.10 | |||
| Day High | $4.16 | P/E | N/A | |||
| Day Low | $4.16 | EPS | $-0.20 | |||
| Volume | 244 | |||||
